18 Devonshire Street
London
W1G 7AQ
info@londonurologyspecialists.co.uk
Women's Health
Bladder Pain Syndrome
Also known as interstitial cystitis, BPS is a chronic condition that causes persistent bladder pain and urinary symptoms — but effective management options are available.
Clinically Reviewed By
Honorary Associate Professor Jeremy Ockrim MD BSc(Hons) FRCS(Urol)
Consultant Urological Surgeon · Reviewed June 2026 · Review due June 2027
What is Bladder Pain Syndrome?
Bladder pain syndrome (BPS), also known as interstitial (inflammatory) cystitis (IC), is a chronic condition characterised by persistent pain or discomfort perceived to be related to the urinary bladder, accompanied by at least one other urinary symptom such as a persistent urge to void or urinary frequency. It is considered a diagnosis of exclusion — meaning it is confirmed only after other conditions that could explain the symptoms have been ruled out.
BPS/IC predominantly affects women, who account for approximately 90% of diagnosed cases. Although it can occur at any age, it is most commonly identified in women between 30 and 50 years of age. The condition has a significant impact on quality of life, affecting sleep, work, relationships, and emotional wellbeing.
It is important to understand that while BPS/IC is a long-term condition, it is not life-threatening, and a wide range of management strategies exist. With the right approach, most patients experience meaningful improvement in their symptoms. Our specialist team works closely with each patient to develop a personalised treatment plan that addresses their specific symptoms and goals.
A diagnosis of exclusion
BPS/IC is diagnosed only after other causes of bladder pain and urinary symptoms — including urinary tract infections, bladder cancer, and endometriosis — have been carefully excluded. This means thorough investigation is an essential part of the diagnostic process before a treatment plan can be developed.
Symptoms of BPS/IC
The hallmark of bladder pain syndrome is chronic pelvic or bladder pain, typically accompanied by urinary urgency and frequency. Symptoms often fluctuate, with periods of flare followed by periods of relative remission. The severity can range from mild discomfort to debilitating pain.
Pain Symptoms
-
›
Chronic bladder/pelvic pain — a persistent ache, pressure, or burning sensation in the lower abdomen or pelvis
-
›
Pain worsens as bladder fills — partially relieved by voiding
-
›
Dyspareunia — pain during or after sexual intercourse, which can significantly affect intimate relationships
-
›
Flares and remissions — symptoms tend to wax and wane, sometimes triggered by stress, diet, or menstrual cycle
Urinary Symptoms
-
›
Urgency — a persistent, compelling need to urinate that is difficult to suppress
-
›
Frequency — needing to pass urine far more often than normal, sometimes 40–60 times per day in severe cases
-
›
Nocturia — waking multiple times during the night to pass urine, leading to chronic sleep disruption
-
›
Small voided volumes — passing only small amounts of urine each time due to reduced functional bladder capacity
-
›
Haematuria & pyuria — blood in the urine and/or a raised white cell count on urine testing are signs of inflammation without evidence of urinary infection
Impact on daily life
BPS/IC can profoundly affect every aspect of daily life — from work productivity and social activities to sleep quality and intimate relationships. Many patients describe feeling isolated by their symptoms. If bladder pain or urinary symptoms are affecting your quality of life, it is important to seek specialist assessment. You do not have to manage alone.
What Causes BPS/IC?
The exact cause of bladder pain syndrome is not fully understood, and it is likely that multiple factors contribute to its development. Current research suggests several mechanisms that may play a role, either alone or in combination:
Defective bladder lining (GAG layer)
The bladder is normally lined with a protective layer of glycosaminoglycans (GAGs) that prevents urine from irritating the bladder wall. In BPS/IC, this protective layer may be damaged or deficient, allowing potassium and other irritants in urine to penetrate the bladder wall and trigger pain and inflammation.
Autoimmune factors
There is evidence to suggest that BPS/IC may involve autoimmune mechanisms, where the body's immune system mistakenly attacks bladder tissue. This theory is supported by the higher prevalence of other autoimmune conditions (such as lupus, Sjögren's syndrome, and thyroid disease) in patients with BPS/IC.
Neurogenic inflammation
Nerve fibres within the bladder wall may become abnormally sensitised, releasing neuropeptides that trigger inflammation and pain even in the absence of infection or injury. This neurogenic inflammation may explain why the bladder becomes hypersensitive over time.
Mast cell activation
Elevated numbers of mast cells have been found in the bladder wall of BPS/IC patients. Mast cells release histamine and other inflammatory mediators that contribute to pain, urgency, and fibrosis of the bladder wall.
Overlap with other chronic pain conditions
BPS/IC frequently co-exists with other chronic pain syndromes, including fibromyalgia, irritable bowel syndrome (IBS), chronic fatigue syndrome, and vulvodynia. This overlap suggests a shared underlying mechanism involving central pain sensitisation, where the nervous system amplifies pain signals.
How is BPS/IC Diagnosed?
Diagnosing bladder pain syndrome requires a careful clinical assessment to confirm the presence of characteristic symptoms and, crucially, to exclude other conditions that can mimic BPS/IC. There is no single definitive test — diagnosis is based on a combination of clinical history, investigations, and exclusion of alternatives.
Clinical history and symptom assessment
A detailed history of your symptoms is the cornerstone of diagnosis. We look for chronic bladder pain, pressure, or discomfort with associated urinary urgency or frequency lasting at least six months. Validated questionnaires (such as the O'Leary–Sant IC Symptom Index) may be used to quantify symptom severity. A targeted pelvic, vaginal and neurological examination is also performed to rule out anatomical or neurological causes.
Bladder diary
You may be asked to keep a bladder diary for several days, recording fluid intake, voiding times, volumes, and pain levels. This provides objective data about your urinary pattern and helps distinguish BPS/IC from overactive bladder.
Exclusion of other conditions
Urine tests are performed to rule out urinary tract infection. Depending on your presentation, further investigations may be arranged to exclude bladder cancer, endometriosis, overactive bladder, and other pelvic conditions. This is a critical step, as treatment depends on arriving at the correct diagnosis. These often include:
-
›
MRI pelvis — cross-sectional imaging to assess the pelvic anatomy (urological, gynaecological, colorectal tracts and pelvic floor) and exclude any structural cause of symptoms
-
›
Video-urodynamic studies — a specialist test measuring bladder pressure and flow rates during filling and voiding, combined with video fluoroscopy to give dynamic pressure and imaging together and exclude a functional cause of symptoms
Cystoscopy with hydrodistension and biopsy
A cystoscopy (camera examination of the bladder) performed under general anaesthetic with hydrodistension (stretching the bladder with fluid) is the most informative investigation. It allows direct visualisation of the bladder lining and can identify inflammatory changes such as petechial haemorrhages and, in more severe cases, Hunner's lesions — distinctive inflammatory patches found in approximately 10–15% of BPS/IC patients. A biopsy is taken to look for the presence of acute and chronic inflammatory changes and mast cells within the bladder wall, which confirms inflammatory (interstitial) cystitis.
Treatment Options
Treatment of BPS/IC is typically multimodal and stepwise, starting with conservative measures and progressing to more advanced therapies if needed. The goal is to reduce pain, improve bladder function, and enhance quality of life. Our specialists work with you to find the right combination of treatments for your individual symptoms.
Dietary & Lifestyle Modifications
Identifying and avoiding dietary triggers is an important first step. Common bladder irritants include:
- ✕ Acidic foods (citrus fruits, tomatoes)
- ✕ Caffeine (coffee, tea, cola)
- ✕ Alcohol
- ✕ Spicy foods
- ✕ Artificial sweeteners
- ✕ Carbonated drinks
Keeping a food and symptom diary can help identify your personal triggers.
Stress management techniques, bladder retraining, and pelvic floor relaxation exercises can also be beneficial. Our clinicians work closely with our specialist nurses and pelvic physiotherapy teams to support you.
Oral Medications
Antihistamines, mast-cell stabilisers, anticholinergics & anti-inflammatories
These are the most commonly used first-line medications for mild BPS/IC. They act to dampen the inflammatory and mast-cell responses within the bladder wall and can reduce urgency, pain, and frequency.
Tricyclic anti-depressant medication (such as amitriptyline)
Helps reduce bladder pain and urgency, and can improve sleep quality. Effects are typically seen after 4–6 weeks of use.
SNRI anti-depressants (e.g. duloxetine)
SNRI anti-depressants such as duloxetine can also be used to dampen nerve responses and reduce symptoms. Effects are typically seen after 4–6 weeks of use.
Neuroleptic medications (pregabalin, gabapentin)
They work by altering brain chemistry (including dopamine and serotonin pathways) and are used when pain is the dominant symptom. They require close medical supervision because of significant potential side effects.
Pentosan polysulfate sodium (Elmiron)
The only oral medication specifically licensed for BPS/IC. It is thought to help repair the damaged GAG layer of the bladder lining. It may take 3–6 months to achieve full benefit.
Important: Long-term use has been associated with a risk of pigmentary maculopathy (a retinal eye condition). Regular ophthalmological monitoring is recommended during treatment, and any changes in vision should be reported promptly.
Pain Specialist Support
When pain is the predominant and poorly controlled symptom, we work closely with our anaesthetic (pain) specialist colleagues, who advise on the appropriate use of oral and transdermal opioid and non-opioid analgesics, offer local and regional nerve blocks, and provide other advanced pain management strategies. Our specialists work in close liaison with this team to offer combined support.
Psychology Support
Chronic conditions have a significant impact on the emotional wellbeing of BPS/IC patients. Our psychology support services offer a number of individual and group cognitive-behavioural strategies and coping techniques. Addressing the brain–bladder connection through evidence-based therapies can help de-escalate pain signals, reduce anxiety, and improve overall quality of life.
Intravesical Therapies
Intravesical therapy involves instilling medication directly into the bladder through a catheter, allowing high concentrations of treatment to reach the bladder lining with minimal systemic side effects.
Hyaluronic acid & chondroitin sulfate instillations
These GAG-replenishing agents are instilled directly into the bladder to help restore the protective lining. A typical course involves weekly instillations for 6–8 weeks, followed by monthly maintenance. Many patients experience significant symptom relief with this approach.
DMSO (dimethyl sulfoxide)
DMSO is an anti-inflammatory agent instilled into the bladder, typically as a series of treatments over several weeks. It has analgesic, anti-inflammatory, and muscle-relaxant properties. Some patients experience a temporary garlic-like taste or odour after treatment.
Parsons' solution (heparin, lidocaine & sodium bicarbonate)
A combination instillation of heparin, lidocaine, and sodium bicarbonate — often called Parsons' solution or a bladder cocktail. Heparin helps restore the bladder's protective GAG layer, lidocaine provides local pain relief, and sodium bicarbonate optimises absorption. This is instilled directly into the bladder via a catheter and retained for 30–60 minutes. Many patients find this particularly effective for pain relief and can be used during acute flares or as a regular treatment course.
Advanced Treatments
For patients whose symptoms do not respond adequately to conservative measures and oral or intravesical treatments, several advanced options are available:
Hydrodistension ± steroid injection
In addition to being a diagnostic tool, hydrodistension (bladder stretching under anaesthesia) can provide therapeutic benefit for some patients. At the same time, steroids can be injected around the bladder base and urethra to dampen inflammation. Symptom relief may last several months, though the procedure is not curative.
Fulguration of Hunner's lesions
If Hunner's lesions are identified during cystoscopy, they can be treated with electrocautery (fulguration) or laser ablation. This targeted treatment can provide significant and sometimes long-lasting pain relief in patients with this subtype of BPS/IC.
Botulinum toxin (Botox) injections
Botox can be injected into the bladder wall during cystoscopy to reduce pain and urgency. It works by blocking nerve signals that trigger bladder muscle contraction and pain. Effects typically last 6–9 months, and the procedure can be repeated.
Note: Botox is used off-label for BPS/IC (it is licensed for overactive bladder). There is a small risk of urinary retention requiring temporary self-catheterisation. Please see our page on Overactive Bladder for further details.
Sacral neuromodulation
A small device is implanted near the sacral nerves that control bladder function. It delivers gentle electrical impulses to modulate the abnormal nerve signals responsible for pain and urgency. A trial stimulation is performed first to confirm benefit before permanent implantation.
Note: Sacral neuromodulation is used off-label for BPS/IC (it is licensed for overactive bladder and voiding dysfunction). Please see the pages on Overactive Bladder, Voiding Dysfunction and Sacral Neuromodulation for further details.
Neobladder & Mitrofanoff (Cystectomy with Urinary Diversion)
In very rare, refractory cases where all other treatments have failed and symptoms are severely affecting quality of life, major surgery including cystectomy with urinary diversion may be considered as a last resort.
Honorary Associate Professor Ockrim is a leading specialist in orthotopic and heterotopic neobladder reconstruction and Mitrofanoff continent urinary diversion for patients with end-stage bladder dysfunction and bladder pain syndrome. He has performed and managed hundreds of these complex cases through his NHS practice at University College London Hospital NHS Trust.
Cystectomy is discussed only after exhaustive specialist and multidisciplinary assessment and consensus. Please see the page on Urinary Diversion for further details.
Multidisciplinary Support
BPS/IC is best managed with a multidisciplinary approach. We work alongside:
Pain management
Specialist pain teams to optimise pain control and reduce reliance on opioids.
Physiotherapy
Pelvic floor physiotherapy to address muscle tension and improve bladder function.
Psychological support
CBT and counselling to help manage the emotional impact of chronic pain.
Living with Bladder Pain Syndrome
Learning to manage BPS/IC is an ongoing process. While the condition is chronic, many patients find that with the right combination of treatments and self-management strategies, they can lead full and active lives.
Flare management
During a flare, focus on rest, hydration with water, and avoiding known triggers. Over-the-counter pain relief such as paracetamol may help. Contact your specialist if flares become more frequent or severe — your treatment plan may need adjustment.
Support groups
Connecting with others who understand your condition can be immensely helpful. Organisations such as the Bladder Health UK charity and the Interstitial Cystitis Association offer patient support groups, educational resources, and online communities where you can share experiences and coping strategies.
Emotional wellbeing
Chronic pain conditions like BPS/IC are associated with higher rates of anxiety and depression. This is not a sign of weakness — it is a recognised consequence of living with persistent pain. We encourage patients to address their emotional wellbeing as part of their overall management plan. Cognitive behavioural therapy (CBT), mindfulness-based stress reduction, and counselling can all be beneficial. Please do not hesitate to discuss this with your specialist.
Meet your Specialists
Assessment and treatment of bladder pain syndrome is led by our experienced consultant urologists. Your care will be personally overseen by one of our senior specialists.
Key Takeaways
Bladder pain syndrome is a real, recognised medical condition — chronic, but increasingly manageable. Careful diagnosis rules out other causes and enables a personalised, multimodal treatment plan combining lifestyle changes, medication and advanced therapies.
Whether you are seeking a diagnosis, exploring new treatment options or needing ongoing support, our specialist team will work with you at every step. Early specialist assessment is the first step towards meaningful improvement in symptoms and quality of life.
Further Reading — BAUS Patient Information
Frequently Asked Questions
Bladder Pain Syndrome (BPS), also known as Interstitial Cystitis (IC), is a chronic condition in which pain, pressure or discomfort is felt in the bladder or pelvic area, typically worsening as the bladder fills and easing on passing urine. It is commonly accompanied by urinary frequency, urgency and nocturia in the absence of infection. Symptoms can range from mild discomfort to severe, life-limiting pain, and the condition is often misdiagnosed initially as recurrent urinary tract infection or overactive bladder.
The exact cause of BPS/IC is not fully understood and is likely to be multi-factorial. Proposed mechanisms include a defective bladder lining (the GAG layer) that allows urinary irritants to penetrate the bladder wall, activation of inflammatory mast cells, abnormal nerve signalling causing neurogenic inflammation, and autoimmune factors. It commonly overlaps with other chronic conditions such as fibromyalgia, IBS, chronic fatigue syndrome and vulvodynia.
There is no single test for BPS/IC — diagnosis is made on the basis of characteristic symptoms once other causes have been excluded. Assessment typically includes a detailed clinical history using validated tools such as the O’Leary-Sant Symptom Index, a 3-day bladder diary, pelvic examination, urine tests to rule out infection, and cystoscopy with hydrodistension to inspect the bladder lining and look for characteristic changes such as Hunner’s lesions or glomerulations. MRI and urodynamic studies may also be used.
A urinary tract infection is caused by bacteria and produces a positive urine culture, and symptoms usually resolve within days of appropriate antibiotic treatment. Bladder Pain Syndrome causes similar symptoms — pain, urgency and frequency — but urine cultures are repeatedly negative and antibiotics do not resolve the symptoms. BPS/IC is a chronic condition thought to relate to bladder lining and nerve dysfunction rather than infection.
Treatment is stepwise and tailored to the individual. First-line options include dietary trigger avoidance, stress management, pelvic floor physiotherapy and oral medications such as antihistamines, amitriptyline or pentosan polysulfate (Elmiron). Second-line treatments include intravesical bladder instillations (hyaluronic acid, chondroitin, DMSO or the ‘Parson’s cocktail’ of heparin and lidocaine). More advanced options include hydrodistension, fulguration of Hunner’s lesions, intravesical Botox and sacral neuromodulation. Reconstructive surgery is reserved for a small number of severely affected patients.
Common bladder irritants include caffeine (coffee, tea, cola), alcohol, carbonated drinks, artificial sweeteners, citrus fruits and juices, tomatoes and tomato-based products, spicy foods, chocolate and aged cheeses. Not everyone reacts to the same triggers, so a structured elimination diet — cutting out common irritants for 2 to 4 weeks then reintroducing one at a time — is the most useful way to identify your personal triggers. Maintaining a bladder diary during this process can help.
Bladder instillations involve passing a small, soft catheter into the bladder to deliver medication directly. Local anaesthetic gel is used to numb the urethra, and instillations containing lidocaine can produce almost immediate pain relief. Treatments are usually given weekly for six weeks and then at intervals depending on response.
There is no single cure for BPS/IC, but the great majority of women achieve meaningful symptom control with a well-tailored, multi-modal treatment plan. Many go on to experience long periods of remission. Success is highest when treatment is led by a specialist team experienced in the condition, combining medical, lifestyle and interventional approaches, and when psychological wellbeing and pelvic floor function are addressed alongside the bladder itself.
Struggling with Bladder Pain?
Book a consultation with one of our specialist consultants to discuss your symptoms and the treatment options available.